Fort Worth OTC Maker Written Up for Lack of Testing

The FDA has slapped Eosera with a Form 483 after finding the over-the-counter (OTC) ear-care product manufacturer failed to validate drug products and properly investigate bacterial contamination.
Source: Drug Industry Daily